Currently out of the existing stock ratings of Andrew Cooper, 143 are a BUY (91.67%), 12 are a HOLD (7.69%), 1 are a SELL (0.64%).

Andrew Cooper

Work Performance Price Targets & Ratings Chart

Analyst Andrew Cooper, currently employed at RAYMOND JAMES, carries an average stock price target met ratio of 48.25% that have a potential upside of 21.71% achieved within 143 days.

Andrew Cooper’s has documented 293 price targets and ratings displayed on 22 stocks. The coverage is on Healthcare, Basic Materials sectors.

Most recent stock forecast was given on HAE, Haemonetics at 10-Aug-2025.

Wall Street Analyst Andrew Cooper

Analyst best performing recommendations are on GH (GUARDANT HEALTH).
The best stock recommendation documented was for GH (GUARDANT HEALTH) at 7/31/2025. The price target of $61 was fulfilled within 21 days with a profit of $20.02 (48.85%) receiving and performance score of 23.26.

Average potential price target upside

of $76.22 (16.11%) on TMO (THERMO FISHER SCIENTIFIC).
of $35.89 (17.1%) on DHR (DANAHER).
of $22.53 (24.44%) on RVTY (REVVITY).

CDNA Caredx CVET Covetrus EXAS EXACT Sciences NEO NeoGenomics NVTA Invitae Corp OSUR OraSure Technologies PROG Progenity QDEL Quidel VCYT Veracyte AVTR Avantor HAE Haemonetics HOLX Hologic LMDX LumiraDx Ltd MYGN Myriad Genetics NTRA Natera DHR Danaher GH Guardant Health TMO Thermo Fisher Scientific RVTY Revvity AZTA Azenta FLGT Fulgent Genetics ITGR Integer Holdings Corp

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Mark Massaro (BTIG)